Next Generation Coronavirus Vaccine In Pill Form, Spray Forms Could Have These Benefits, Dr Nesheiwat Says – fr

0
11
Next Generation Coronavirus Vaccine In Pill Form, Spray Forms Could Have These Benefits, Dr Nesheiwat Says – fr


The coronavirus vaccine could take a new form in pill form and possibly nasal sprays, opening a window of new opportunities for pandemic recovery.

Fox News medical contributor and CityMD medical director Dr Janette Nesheiwat told “Kudlow” on Monday that the widest range of options would allow patients alternatives that are right for them, including people who simply have an aversion to it. for needles.

“It’s really going to have a significant positive impact with the rollout of immunization in the country and around the world,” she said. “So being able to get the COVID vaccine in pill form, in tablet form, or even in nasal spray form is really going to go a long way and is going to help us, especially for future pandemics, for future epidemics. . . “

EFFECTIVE COVID-19 PILL IN PRELIMINARY TESTING MAY BE THE “HOLY GRAIL” OF PANDEMIC, DR. MARC SIEGEL SAYS

Nesheiwat said these variations in inoculation could be more beneficial for patients than the traditional injectable in terms of side effects. She explained that the technology is not new and is being used in other treatments such as Vivotif Oral vaccine pill for typhoid fever, which she has witnessed to last longer and offer better protection. to patients.

“You will feel better too,” she said. “You might not have those side effects that you have with shooting. “

GET FOX BUSINESS ON THE ROAD BY CLICKING HERE

The doctor clarified that these benefits have not yet been proven in an alternative to the COVID vaccine, but according to other treatments, they are very likely to leave less severe reaction.

According to the Wall Street Journal, US pharmaceutical companies like Sanofi SA, Altimmune Inc. and Gritstone Oncology Inc. are in early to mid-stage testing for next-generation vaccines. These alternatives will be easier to store and ship and may have the potential to create longer lasting immune responses.

A vaccine option in pill or nasal spray form is unlikely to hit the market until late 2021 or 2022 depending on the success of the trials.

CLICK HERE TO LEARN MORE ABOUT FOX BUSINESS

LEAVE A REPLY

Please enter your comment!
Please enter your name here